Leonid Beigelman
Board Member
Aligos Therapeutics, Inc. (ALGS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2018-01-01–present
-
2018-01-01–2023-11-09
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Aligos Therapeutics, Inc. (ALGS) | Former President | $444,265 | $955,127 |
| 2022 | Aligos Therapeutics, Inc. (ALGS) | Former President | $464,094 | $1,378,244 |
| 2021 | Aligos Therapeutics, Inc. (ALGS) | Ph.D., President | $464,094 | $702,253 |
| 2020 | Aligos Therapeutics, Inc. (ALGS) | Ph.D., President | $415,033 | $4,420,192 |
| 2019 | Aligos Therapeutics, Inc. (ALGS) | Ph.D., President | $400,000 | $554,957 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.